Galera Therapeutics Inc.
(GRTX)
undefined
undefined%
At close: undefined
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Net Income | -59.08M | -62.22M | -80.53M | -74.22M | -51.93M | -23.68M | -23.55M |
| Depreciation & Amortization | 259.00K | 114.00K | 778.00K | 368.00K | 267.00K | 127.00K | 84.00K |
| Stock-Based Compensation | 5.56M | 7.16M | 7.23M | 5.54M | 2.39M | 865.00K | 726.00K |
| Other Working Capital | -721.00K | 1.48M | -2.53M | 2.71M | -732.00K | -1.29M | -19.00K |
| Other Non-Cash Items | 11.34M | 11.57M | 7.19M | 4.88M | 3.04M | 220.00K | 1.61M |
| Deferred Income Tax | - | -70.00K | - | -16.00K | 232.00K | - | - |
| Change in Working Capital | -2.93M | 17.00K | -2.63M | 3.91M | -655.00K | 298.00K | -671.00K |
| Operating Cash Flow | -44.85M | -43.43M | -67.96M | -59.54M | -46.66M | -22.17M | -23.41M |
| Capital Expenditures | -59.00K | -25.00K | -283.00K | -457.00K | -633.00K | -347.00K | -319.00K |
| Acquisitions | - | -24.02K | -5.52K | -37.00K | 27.19K | - | - |
| Purchase of Investments | -22.64M | -59.89M | -71.98M | -67.75M | -123.19M | -71.19M | -9.92M |
| Sales Maturities Of Investments | 49.99M | 83.91M | 77.50M | 104.75M | 96.00M | 12.50M | 33.75M |
| Other Investing Acitivies | - | 24.02K | 5.52K | 37.00K | -27.19K | -58.69M | 23.83M |
| Investing Cash Flow | 27.29M | 23.99M | 5.24M | 36.55M | -27.82M | -59.04M | 23.51M |
| Debt Repayment | - | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - | - |
| Dividend Paid | - | - | - | - | - | - | - |
| Other Financial Acitivies | 2.20M | 81.00K | 58.77M | 20.51M | 20.01M | 89.84M | - |
| Financial Cash Flow | 31.50M | 3.89M | 66.71M | 20.51M | 78.03M | 89.84M | - |
| Net Cash Flow | 13.94M | -15.54M | 3.99M | -2.48M | 3.54M | 8.64M | 106.00K |
| Free Cash Flow | -44.91M | -43.45M | -68.24M | -59.99M | -47.29M | -22.51M | -23.73M |